NBCD A/S: Financial statements 2020
CVR: 30582462
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
NBCD A/S (CVR 30582462) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 59,688,951 and a net result of DKK 40,503,062 compared with DKK 33,733,642 the year before. That is an increase of 22% compared with the year before. Equity in the 2020 report amounted to DKK 71,989,300. The solvency ratio was 57.6%. The company had 23 employees in the financial year.
- Gross Profit
- DKK 59,688,951
- Profit/Loss
- DKK 40,503,062
- Equity
- DKK 71,989,300
- Total Assets
- DKK 125,044,596
- Employees
- 23
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 59.7 mio. | 40.5 mio. | 72 mio. | 23 |
| 2019 | - | 48.9 mio. | 33.7 mio. | 36.5 mio. | 20 |
| 2018 | - | 26.7 mio. | 16.3 mio. | 17.8 mio. | 25 |
| 2017 | - | 24.6 mio. | 20.8 mio. | 21.5 mio. | - |
| 2016 | - | 12.7 mio. | 14 mio. | 9.7 mio. | - |
Official annual report
How creditworthy is NBCD A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of December 10, 2020, Jeppe Ragnar Andersen has joined the board of directors of NBCD A/S.
As of December 10, 2020, Celine Infeld has joined the board of directors of NBCD A/S.
As of December 10, 2020, Karl Sebastian Inger has joined the board of directors of NBCD A/S.
As of December 10, 2020, Claus Henrik Christiansen has left the board of directors of NBCD A/S.
As of December 10, 2020, Bente Juel Christiansen has left the board of directors of NBCD A/S.
As of December 10, 2020, Henrik Bernt Sanders has left the board of directors of NBCD A/S.
As of December 10, 2020, Thomas Nielsen has left the board of directors of NBCD A/S.
On September 4, 2020, the company changed its name from NORDIC BIOSCIENCE CLINICAL DEVELOPMENT A/S to NBCD A/S.
As of July 1, 2020, Bente Juel Christiansen has joined the board of directors of NBCD A/S.
As of July 1, 2020, Henrik Bernt Sanders has joined the board of directors of NBCD A/S.
About NBCD A/S
NBCD A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2007. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named NORDIC BIOSCIENCE CLINICAL DEVELOPMENT A/S and NORDIC BIOSCIENCE PROJECT 2 A/S. The management consists of Jeppe Ragnar Andersen and Mark Høgh Gandrup. The board consists of Pierre Khaitrine (chair), Jeppe Ragnar Andersen and José Ignacio Pfeifer. The company is owned by Sanos Holding A/S. The company has 24 employees (2018). In 2025, the company reported a gross profit of DKK 31,583,144 and a net result of DKK 9,222,892 compared with DKK 52,621,101 the year before. Equity in the 2025 report amounted to DKK 136,144,994.